Suchergebnisse - "Lau, Kristy T K"

PubPharm (17)

1

Real-world effectiveness of early molnupiravir or nirmatrelvir-ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave : a retrospective cohort study

enthalten in: The Lancet. Infectious diseases | 2022

von Wong, C. | Au, I. | Lau, K. | +3

CommentIn: Lancet Infect Dis. 2022 Dec;22(12):1650-1651. - PMID 36029797

2

Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong : an observational study

enthalten in: Lancet (London, England) | 2022

von Wong, C. | Au, I. | Lau, K. | +3

CommentIn: Lancet. 2022 Oct 8;400(10359):1175-1176. - PMID 36215994

3

Optimal Timing of Remdesivir Initiation in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Administered With Dexamethasone

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Wong, C. | Lau, K. | Au, I. | +4

4

Remdesivir use and risks of acute kidney injury and acute liver injury among patients hospitalised with COVID-19 : a self-controlled case series study

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Wong, C. | Au, I. | Cheng, W. | +8

CommentIn: Aliment Pharmacol Ther. 2022 Jun;55(11):1457-1458. - PMID 35538354

5

Real-world effectiveness of early molnupiravir and nirmatrelvir/ritonavir among hospitalized, non-oxygen-dependent COVID-19 patients on admission during Hong Kong’s Omicron BA.2 wave: an observational study

enthalten in: bioRxiv.org | 2022

von Wong, C. | Au, I. | Lau, K. | +3

6

Editorial : liver and kidney injury from remdesivir-an issue not as much as its purpose. Authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Wong, C. | Au, I. | Cheng, W. | +8

CommentOn: Aliment Pharmacol Ther. 2022 Jul;56(1):121-130. - PMID 35318694

7

Slower Recovery with Early Lopinavir/Ritonavir use in Pediatric COVID-19 Patients : A Retrospective Observational Study

enthalten in: Paediatric drugs | 2022

von Wong, C. | Low, M. | Kwok, A. | +8

8

Clinical Improvement, Outcomes, Antiviral Activity, and Costs Associated With Early Treatment With Remdesivir for Patients With Coronavirus Disease 2019 (COVID-19)

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Wong, C. | Lau, K. | Au, I. | +3

9

Slower Recovery with Early Lopinavir/Ritonavir use in Pediatric COVID-19 Patients: A Retrospective Observational Study

enthalten in: Pediatric drugs | 2022

von Wong, C. | Low, M. | Kwok, A. | +8

10

Slower Recovery with Early Lopinavir/Ritonavir use in Pediatric COVID-19 Patients: A Retrospective Observational Study

enthalten in: Pediatric drugs | 2022

von Wong, C. | Low, M. | Kwok, A. | +8